Gujarat Themis Biosyn Ltd.

315.9

-1.9 (-0.6%)growUp

As on January 27, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap3,462 Cr
P/E Ratio70.58
Dividend Yield0.21 %
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open316.25
High319.85
NSE SymbolGUJTHEM
Close315.9
Low306.25
BSE Symbol506879
Previous Years High/Low
1 Year High479
3 Year High479
5 Year High479
1 Year Low208
3 Year Low208
5 Year Low208

Technicals


IndicatorsValueSignal
5-DMA324.47Bearish
10-DMA346.08Bearish
20-DMA386.32Bearish
50-DMA398.75Bearish
100-DMA409.3Bearish
200-DMA371.34Bearish

Historical Performance


1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 70.58, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries a high beta of 2.2, implying higher volatility and elevated risk.
  • In the last financial year, the company reported an EBITDA of ₹713 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹1508 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 1297543.7
No. of Shares: 4107 (Approx)
Performance:29.8%
P/L: ₹297543.7
NIFTY Performance: 9.7%
1 day Top Gainers
SymbolChange%
HOMEFIRST1251.7(13%)
KARURVYSYA292.55(10%)
JSL810.05(9%)
SONACOMS487.8(7%)
GRSE2387.6(7%)
1 Day Top Losers
SymbolChange%
SBFC89.97(-12%)
SYNGENE489.7(-10%)
JSWENERGY440.05(-8%)
SUNTV529.9(-6%)
GODREJCP1173.9(-5%)
GRAVITA1466.3(-5%)
CREDITACC1320.6(-5%)
NUVAMA1265.2(-5%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

77.5%

42.21

1 Month Performance

NGL Fine-Chem Ltd.

18.4%

1566.2

1 Month Performance

Ind-Swift Laboratories Ltd.

16.9%

107.02

1 Month Performance

Torrent Pharmaceuticals Ltd.

4.7%

3997.4

1 Month Performance

Acutaas Chemicals Ltd.

4.5%

1728

1 Month Performance

Emcure Pharmaceuticals Ltd.

4%

1484.6

1 Month Performance

Alkem Laboratories Ltd.

4%

5754

1 Month Performance

JB Chemicals & Pharmaceuticals Ltd.

3.2%

1877.5

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month